VP, US Market Access
BioCryst Pharmaceuticals | |
United States, North Carolina, Durham | |
4505 Emperor Boulevard (Show on map) | |
Nov 23, 2025 | |
|
Description
JOB SUMMARY: The VP, US Market Access will lead the development and execution of market access strategies to ensure optimal reimbursement, pricing, and patient access for the company's rare disease portfolio. This executive will be responsible for developing the organization's access, contracting, and product pricing strategies across all products within the portfolio. Responsibilities also include development and evolution of payer value propositions, and stakeholder engagement across the US markets. The role requires a strategic leader with deep expertise in rare diseases, payer relationship management, strong cross-functional collaboration skills, and a proven track record of navigating complex reimbursement landscapes. #LI-REMOTE ESSENTIAL DUTIES & RESPONSIBILITIES:
EXPERIENCE & QUALIFICATIONS:
The statements in this position description are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not intended to be construed as an exhaustive list of responsibilities, duties, and skills required of personnel so classified. The manager may assign additional responsibilities and assignments from time to time. BioCryst is an equal opportunity employer and is committed to providing equal employment opportunities without regard to age, race, religion, sex, sexual orientation, gender identity, national origin, Veterans status, disability and/or other protected class characteristics. Additionally, BioCryst is committed to achieving its business objectives in compliance with all federal, state and local law. Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities
This employer is required to notify all applicants of their rights pursuant to federal employment laws. For further information, please review the Know Your Rights notice from the Department of Labor. | |
Nov 23, 2025